Integra LifeSciences to sell some neurosurgery assets to Natus Medical Incorporated
Integra LifeSciences Holdings Corporation is to sell certain neurosurgery assets to Natus Medical for USD47.5 million. The divestiture is contingent on the consummation of Integra’s proposed acquisition of Codman Neurosurgery from Johnson & Johnson. As part of this divestiture, Integra will sell the global Camino® ICP monitoring product line, including